KLK3 and prostate carcinoma: Further, a phase I trial of white button mushroom (WBM) in 36 patients with recurrent prostate cancer revealed that WBM suppressed prostate-specific antigen (PSA) as well as potentially modulated the biology of some prostate cancer patients [87].